target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id CYP2C8,1325,P10632,Human,phenelzine,7266,,3675,NNCCc1ccccc1,"InChI=1S/C8H12N2/c9-10-7-6-8-4-2-1-3-5-8/h1-5,10H,6-7,9H2",RMUCZJUITONUFY-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pKi,,5.14,,Ki,,7266.0,,=,,,,16248836, CYP2C8,1325,P10632,Human,"compound 51 [Crosignani et al., 2011]",8777,,49872868,CCC(=O)N(c1cc(F)cc(c1)c1nn[nH]n1)Cc1ccc(cc1)OC(F)(F)F,"InChI=1S/C18H15F4N5O2/c1-2-16(28)27(10-11-3-5-15(6-4-11)29-18(20,21)22)14-8-12(7-13(19)9-14)17-23-25-26-24-17/h3-9H,2,10H2,1H3,(H,23,24,25,26)",XQIZEBWLPMOVGN-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.37,,IC50,,43.0,,=,,,,24900284, CYP2C8,1325,P10632,Human,voxelotor,10559,,71602803,O=Cc1c(cccc1O)OCc1cccnc1c1ccnn1C(C)C,"InChI=1S/C19H19N3O3/c1-13(2)22-16(8-10-21-22)19-14(5-4-9-20-19)12-25-18-7-3-6-17(24)15(18)11-23/h3-11,13,24H,12H2,1-2H3",FWCVZAQENIZVMY-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,5.1,,IC50,,7900.0,,=,Measuring inhibition of CYP2C8 activity using paclitaxel as substrate.,,,28337324,